Global Neonatal Respiratory Distress Syndrome Treatment Market Growth (Status and Outlook) 2025-2031
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size (2020-2031) 2.1.2 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Neonatal Respiratory Distress Syndrome Treatment by Country/Region (2020, 2024 & 2031) 2.2 Neonatal Respiratory Distress Syndrome Treatment Segment by Type 2.2.1 Oxygen Therapy 2.2.2 Surfactant Therapy 2.2.3 Others 2.3 Neonatal Respiratory Distress Syndrome Treatment Market Size by Type 2.3.1 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2020-2025) 2.4 Neonatal Respiratory Distress Syndrome Treatment Segment by Application 2.4.1 Hospitals 2.4.2 Home Care 2.4.3 Others 2.5 Neonatal Respiratory Distress Syndrome Treatment Market Size by Application 2.5.1 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2020-2025) 3 Neonatal Respiratory Distress Syndrome Treatment Market Size by Player 3.1 Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Player 3.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Player (2020-2025) 3.1.2 Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player (2020-2025) 3.2 Global Neonatal Respiratory Distress Syndrome Treatment Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Neonatal Respiratory Distress Syndrome Treatment by Region 4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) 4.2 Global Neonatal Respiratory Distress Syndrome Treatment Annual Revenue by Country/Region (2020-2025) 4.3 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2020-2025) 4.4 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2020-2025) 4.5 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2020-2025) 4.6 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2020-2025) 5 Americas 5.1 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) 5.2 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) 5.3 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) 6.2 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) 6.3 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) 7.2 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) 7.3 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment by Region (2020-2025) 8.2 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) 8.3 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Neonatal Respiratory Distress Syndrome Treatment Market Forecast 10.1 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2026-2031) 10.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2026-2031) 10.1.2 Americas Neonatal Respiratory Distress Syndrome Treatment Forecast 10.1.3 APAC Neonatal Respiratory Distress Syndrome Treatment Forecast 10.1.4 Europe Neonatal Respiratory Distress Syndrome Treatment Forecast 10.1.5 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Forecast 10.2 Americas Neonatal Respiratory Distress Syndrome Treatment Forecast by Country (2026-2031) 10.2.1 United States Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.2.2 Canada Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.2.3 Mexico Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.2.4 Brazil Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.3 APAC Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2026-2031) 10.3.1 China Neonatal Respiratory Distress Syndrome Treatment Market Forecast 10.3.2 Japan Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.3.3 Korea Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.3.4 Southeast Asia Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.3.5 India Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.3.6 Australia Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.4 Europe Neonatal Respiratory Distress Syndrome Treatment Forecast by Country (2026-2031) 10.4.1 Germany Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.4.2 France Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.4.3 UK Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.4.4 Italy Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.4.5 Russia Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.5 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2026-2031) 10.5.1 Egypt Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.5.2 South Africa Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.5.3 Israel Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.5.4 Turkey Market Neonatal Respiratory Distress Syndrome Treatment Forecast 10.6 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Type (2026-2031) 10.7 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Neonatal Respiratory Distress Syndrome Treatment Forecast 11 Key Players Analysis 11.1 Medtronic 11.1.1 Medtronic Company Information 11.1.2 Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 Medtronic Main Business Overview 11.1.5 Medtronic Latest Developments 11.2 Dragerwerk 11.2.1 Dragerwerk Company Information 11.2.2 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Dragerwerk Main Business Overview 11.2.5 Dragerwerk Latest Developments 11.3 GE HealthCare 11.3.1 GE HealthCare Company Information 11.3.2 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 GE HealthCare Main Business Overview 11.3.5 GE HealthCare Latest Developments 11.4 Koninklijke Philips 11.4.1 Koninklijke Philips Company Information 11.4.2 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.4.4 Koninklijke Philips Main Business Overview 11.4.5 Koninklijke Philips Latest Developments 11.5 Smiths Medical 11.5.1 Smiths Medical Company Information 11.5.2 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.5.4 Smiths Medical Main Business Overview 11.5.5 Smiths Medical Latest Developments 11.6 Fisher & Paykel Healthcare 11.6.1 Fisher & Paykel Healthcare Company Information 11.6.2 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.6.4 Fisher & Paykel Healthcare Main Business Overview 11.6.5 Fisher & Paykel Healthcare Latest Developments 11.7 IBIO 11.7.1 IBIO Company Information 11.7.2 IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.7.4 IBIO Main Business Overview 11.7.5 IBIO Latest Developments 11.8 Windtree Therapeutics 11.8.1 Windtree Therapeutics Company Information 11.8.2 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.8.4 Windtree Therapeutics Main Business Overview 11.8.5 Windtree Therapeutics Latest Developments 11.9 Synthetic Biologics 11.9.1 Synthetic Biologics Company Information 11.9.2 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.9.4 Synthetic Biologics Main Business Overview 11.9.5 Synthetic Biologics Latest Developments 11.10 Synairgen 11.10.1 Synairgen Company Information 11.10.2 Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offered 11.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2020-2025) 11.10.4 Synairgen Main Business Overview 11.10.5 Synairgen Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Neonatal Respiratory Distress Syndrome Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Oxygen Therapy Table 4. Major Players of Surfactant Therapy Table 5. Major Players of Others Table 6. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 7. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) & ($ millions) Table 8. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2020-2025) Table 9. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 10. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) & ($ millions) Table 11. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2020-2025) Table 12. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Player (2020-2025) & ($ millions) Table 13. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player (2020-2025) Table 14. Neonatal Respiratory Distress Syndrome Treatment Key Players Head office and Products Offered Table 15. Neonatal Respiratory Distress Syndrome Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) & ($ millions) Table 19. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2020-2025) Table 20. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Country/Region (2020-2025) & ($ millions) Table 21. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Country/Region (2020-2025) Table 22. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) & ($ millions) Table 23. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country (2020-2025) Table 24. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) & ($ millions) Table 25. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2020-2025) Table 26. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) & ($ millions) Table 27. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2020-2025) Table 28. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) & ($ millions) Table 29. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2020-2025) Table 30. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) & ($ millions) Table 31. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) & ($ millions) Table 32. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) & ($ millions) Table 33. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country (2020-2025) Table 34. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) & ($ millions) Table 35. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) & ($ millions) Table 36. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) & ($ millions) Table 37. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) & ($ millions) Table 38. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Neonatal Respiratory Distress Syndrome Treatment Table 40. Key Market Challenges & Risks of Neonatal Respiratory Distress Syndrome Treatment Table 41. Key Industry Trends of Neonatal Respiratory Distress Syndrome Treatment Table 42. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Region (2026-2031) & ($ millions) Table 43. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Region (2026-2031) Table 44. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Type (2026-2031) & ($ millions) Table 45. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Application (2026-2031) & ($ millions) Table 46. Medtronic Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 47. Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 48. Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 49. Medtronic Main Business Table 50. Medtronic Latest Developments Table 51. Dragerwerk Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 52. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 53. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 54. Dragerwerk Main Business Table 55. Dragerwerk Latest Developments Table 56. GE HealthCare Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 57. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 58. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 59. GE HealthCare Main Business Table 60. GE HealthCare Latest Developments Table 61. Koninklijke Philips Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 62. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 63. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 64. Koninklijke Philips Main Business Table 65. Koninklijke Philips Latest Developments Table 66. Smiths Medical Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 67. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 68. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 69. Smiths Medical Main Business Table 70. Smiths Medical Latest Developments Table 71. Fisher & Paykel Healthcare Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 72. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 73. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 74. Fisher & Paykel Healthcare Main Business Table 75. Fisher & Paykel Healthcare Latest Developments Table 76. IBIO Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 77. IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 78. IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 79. IBIO Main Business Table 80. IBIO Latest Developments Table 81. Windtree Therapeutics Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 82. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 83. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 84. Windtree Therapeutics Main Business Table 85. Windtree Therapeutics Latest Developments Table 86. Synthetic Biologics Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 87. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 88. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 89. Synthetic Biologics Main Business Table 90. Synthetic Biologics Latest Developments Table 91. Synairgen Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors Table 92. Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offered Table 93. Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 94. Synairgen Main Business Table 95. Synairgen Latest Developments List of Figures Figure 1. Neonatal Respiratory Distress Syndrome Treatment Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Neonatal Respiratory Distress Syndrome Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Neonatal Respiratory Distress Syndrome Treatment Sales Market Share by Country/Region (2024) Figure 8. Neonatal Respiratory Distress Syndrome Treatment Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type in 2024 Figure 10. Neonatal Respiratory Distress Syndrome Treatment in Hospitals Figure 11. Global Neonatal Respiratory Distress Syndrome Treatment Market: Hospitals (2020-2025) & ($ millions) Figure 12. Neonatal Respiratory Distress Syndrome Treatment in Home Care Figure 13. Global Neonatal Respiratory Distress Syndrome Treatment Market: Home Care (2020-2025) & ($ millions) Figure 14. Neonatal Respiratory Distress Syndrome Treatment in Others Figure 15. Global Neonatal Respiratory Distress Syndrome Treatment Market: Others (2020-2025) & ($ millions) Figure 16. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application in 2024 Figure 17. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player in 2024 Figure 18. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2020-2025) Figure 19. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size 2020-2025 ($ millions) Figure 20. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size 2020-2025 ($ millions) Figure 21. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size 2020-2025 ($ millions) Figure 22. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2020-2025 ($ millions) Figure 23. Americas Neonatal Respiratory Distress Syndrome Treatment Value Market Share by Country in 2024 Figure 24. United States Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 25. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 26. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 28. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region in 2024 Figure 29. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2020-2025) Figure 30. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2020-2025) Figure 31. China Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 32. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 33. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 34. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 35. India Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 36. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 37. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country in 2024 Figure 38. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2020-2025) Figure 39. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2020-2025) Figure 40. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 41. France Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 42. UK Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 43. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 44. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 45. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2020-2025) Figure 46. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2020-2025) Figure 47. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2020-2025) Figure 48. Egypt Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 49. South Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 50. Israel Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 51. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 52. GCC Countries Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2020-2025 ($ millions) Figure 53. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 54. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 55. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 56. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 57. United States Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 58. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 59. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 60. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 61. China Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 62. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 63. Korea Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 64. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 65. India Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 66. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 67. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 68. France Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 69. UK Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 70. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 71. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 72. Egypt Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 73. South Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 74. Israel Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 75. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions) Figure 76. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Type (2026-2031) Figure 77. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Application (2026-2031) Figure 78. GCC Countries Neonatal Respiratory Distress Syndrome Treatment Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Medtronic|||Dragerwerk|||GE HealthCare|||Koninklijke Philips|||Smiths Medical|||Fisher & Paykel Healthcare|||IBIO|||Windtree Therapeutics|||Synthetic Biologics|||Synairgen